ESMO Shares Recommendations to Support Cancer Research and Clinical Trials in Europe By Ogkologos - May 28, 2026 87 0 Facebook Twitter Google+ Pinterest WhatsApp EU Competitiveness Council (Research) Source RELATED ARTICLESMORE FROM AUTHOR ESMO Welcomes the WHO Global Status Report on Cancer with Key Recommendations for Equitable Cancer Care Lorlatinib Continues to Show Long-Term Benefit in Newly-Diagnosed Patients with Advanced ALK-positive NSCLC GLP-1 Receptor Agonist Use Associated with a Significantly Lower Short-Term Incidence of Obesity-Associated Cancers Among Obese Individuals Without Diabetes MOST POPULAR Quarantined Cruise Ship Passenger Concerned She Won’t Make It Home for... March 11, 2020 Zantac Contains A Cancer-Causing Chemical And Now Breast Cancer Patients Are... September 30, 2019 Adding Lurbinectedin to First-Line Atezolizumab Maintenance Treatment Prolongs Survival Over Atezolizumab... July 14, 2025 Artificial Intelligence Brings Pancreatic Cancer Screening One Step Closer to Reality... July 2, 2020 Load more HOT NEWS FDA Approves Durvalumab for Locally Advanced or Metastatic Biliary Tract Cancer “Scars are Tattoos with Better Stories” Many Breast Cancer Patients Use Cannabis to Manage Symptoms But Don’t... ESMO Immuno-Oncology Congress 2024, Geneva, Switzerland, 11-13 December
